Skip Nav DestinationYou do not currently have access to this content.
2 potential biomarkers for ASD clear first step in FDA drug development tool qualification process
April 1, 2021
from the Food and Drug Administration’s Office of Pediatric Therapeutics and Center for Drug Evaluation and Research, Division of Pediatric and Maternal Health and Division of Psychiatry
Article type: FDA Update
Don't already have an account? Register